Public Policy and Pharmaceutical Innovation
نویسنده
چکیده
Historically, new drug introductions have played a central role in medical progress and the availability of cost-effective therapies. Nevertheless, public policy toward pharmaceuticals has been characterized in recent times by increasingly stringent regulatory controls, shorter effective patent terms, and increased encouragement of generic product usage. This has had an adverse effect on the incentives and capabilities of firms to undertake new drug research and development activity. The industry has experienced sharply rising research and development costs, declining annual new drug introductions, and fewer independent sources of drug development. This paper considers the effects of government regulatory policies on the pharmaceutical innovation process from several related perspectives. It also examines the merits of current public policy proposals designed to stimulate drug innovation including patent restoration and various regulatory reform measures.
منابع مشابه
Toward a definition of pharmaceutical innovation
ONGOING DEBATES IN THE PHARMACEUTICAL SECTOR ABOUT INTELLECTUAL PROPERTY, PRICING AND REIMBURSEMENT, AND PUBLIC RESEARCH INVESTMENTS HAVE A COMMON DENOMINATOR: the pursuit of innovation. However, there is little clarity about what constitutes a true pharmaceutical innovation, and as a result there is confusion about what kind of new products should be pursued, protected and encouraged through h...
متن کاملRevisiting the Relationship Between Systems of Innovation and Health Systems: A Response to Recent Commentaries
متن کامل
Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications
Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications Based on the proceedings of a University of Michigan Center for Medication Use, Policy and Economics symposium, April 18–20, 2004,Washington, D.C. HIGHLIGHTS • Legislation and Pharmaceutical Reimportation • Price Regulation and Innovation • Price Differentials Between Canada and the U...
متن کاملLeadership for Innovation in Healthcare: An Exploration
Although leadership has been studied extensively, most research has focused on the political and military spheres. More recent work has also examined the role of leadership in sectors such as manufacturing and technology, both areas where it is essential to encourage and nurture innovation. Yet, in the health sector, where innovation is now high on the policy agenda in many countries, there is ...
متن کاملSubmission from : Section 2: Contribution
Much of the current debate on health care goals, medical innovation and trade rules focuses on the misalignment between the need to provide incentives to innovation – mainly through a tight intellectual property (IPR) regime – and the resulting negative consequences in terms of access to medicines. While this clash is certainly crucial, this contribution focuses on a different aspect of the mis...
متن کامل